Danaher Corp
NYSE:DHR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
224.58
280.76
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Danaher Corp
Wall Street
Price Targets
DHR Price Targets Summary
Danaher Corp
According to Wall Street analysts, the average 1-year price target for
DHR
is 292.34 USD
with a low forecast of 238.36 USD and a high forecast of 330.75 USD.
DHR Last Price Targets
Danaher Corp
The latest public price target was made on Oct 31, 2024 by
Doug Schenkel
from
Wolfe Research
,
who expects
DHR
stock to
rise by 24%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Doug Schenkel
Wolfe Research
|
285
USD
Upside 24% |
1 month ago
Oct 31, 2024
|
Wolfe Research Upgrades Danaher (DHR) to Outperform
StreetInsider
|
Catherine Schulte
Robert W. Baird
|
277
USD
Upside 21% |
2 months ago
Oct 23, 2024
|
Danaher (DHR) PT Lowered to $277 at Baird
StreetInsider
|
Paul Knight
KeyBanc
|
310
USD
Upside 35% |
2 months ago
Oct 23, 2024
|
Danaher (DHR) PT Raised to $310 at KeyBanc
StreetInsider
|
|
Puneet Souda
Leerink Partners
|
275
USD
Upside 20% |
2 months ago
Oct 23, 2024
|
Danaher (DHR) PT Lowered to $275 at Leerink Partners
StreetInsider
|
Jacob Johnson
Stifel Nicolaus
|
315
USD
Upside 37% |
2 months ago
Oct 1, 2024
|
Danaher Is Poised For 'A Good Year In Bioprocessing': Analyst
Benzinga
|
Justin Bowers
Deutsche Bank
|
270
USD
Upside 18% |
8 months ago
Apr 23, 2024
|
Deutsche Bank on Danaher (DHR): 'We expect strength in DHR stock'
StreetInsider
|
Rajesh Kumar
HSBC
|
280
USD
Upside 22% |
8 months ago
Apr 17, 2024
|
HSBC upgrades Danaher to Buy on biotech funding recovery
TheFly
|
Paul Knight
Loop Capital Markets
|
300
USD
Upside 31% |
1 year ago
Sep 27, 2023
|
Danaher Bears The Brunt Of Macro Woes: Analyst Flags Lower Demand, Reduced Funding & Weakness In China
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DHR's stock price target?
Price Target
292.34
USD
According to Wall Street analysts, the average 1-year price target for
DHR
is 292.34 USD
with a low forecast of 238.36 USD and a high forecast of 330.75 USD.
What is Danaher Corp's Revenue forecast?
Projected CAGR
6%
For the last 8 years the
compound annual growth rate for
Danaher Corp's revenue is
7%.
The projected
CAGR
for the next 4 years is
6%.
What is Danaher Corp's Operating Income forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
Danaher Corp's operating income is
11%.
The projected
CAGR
for the next 4 years is
16%.
What is Danaher Corp's Net Income forecast?
Projected CAGR
14%
For the last 8 years the
compound annual growth rate for
Danaher Corp's net income is
4%.
The projected
CAGR
for the next 4 years is
14%.
You don't have any saved screeners yet
